Parkway Life Real Estate Investment Trust (C2PU) Fair Value & Analysis
Real Estate · SG · Market cap 2.7B SGD
Fair value as of: Aug 13, 2026
From 16 valuation models · updated 4 days ago
Share price −1.4% over the past month.
A solid business, but screening 51% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (2.81 SGD). The favourable scenario is already priced in.
- Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (1.17 SGD to 2.81 SGD) leaves room in how you read the outcome.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 3.03 SGD – 4.44 SGD · fair‑value band 1.17 SGD – 2.81 SGD · the 4.10 SGD price screens above the 1.99 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Parkway Life Real Estate Investment Trust (C2PU) currently trades at 4.10 SGD, while our model-based Fair Value estimate is 1.99 SGD, implying the stock looks roughly 51.5% overvalued today. The Quality Score stands at 53/100 (solid quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Trailing-twelve-month revenue stands at 155M SGD. Revenue declined 2.1% year over year. It earns a return on equity of 10.0%. Net debt stands at 836M SGD. Fundamentals as of Aug 13, 2026
Our scenario range runs from 1.17 SGD (bear case) to 2.81 SGD (bull case); at 4.10 SGD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 6% below its 52-week high and 7% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -49% fair-value upside, at -51%, C2PU screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Economic Profit (2.36 SGD) versus DCF Models (0.4600 SGD). Highest evidence: Growth DCF (80).
Notify me when C2PU reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 60
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Parkway Life Real Estate Investment Trust is a unit trust constituted pursuant to the trust deed (as amended) (the Trust Deed) between Parkway Trust Management Limited (the Manager) and HSBC Institutional Trust Services (Singapore) Limited (the Trustee).
Full company description
Parkway Life Real Estate Investment Trust is a unit trust constituted pursuant to the trust deed (as amended) (the Trust Deed) between Parkway Trust Management Limited (the Manager) and HSBC Institutional Trust Services (Singapore) Limited (the Trustee). On 12 July 2007, the Trust was declared as an authorized unit trust scheme under the Trustees Act, Chapter 337. The Trustee is under a duty to take into custody and hold the assets of the Trust and its subsidiaries (the Group) in trust for the holders (Unitholders) of units in the Trust. On 23 August 2007, the Trust was admitted to the Official List of the Singapore Exchange Securities Trading Limited and was included under the Central Provident Fund Investment Scheme on the same date. The principal activity of the Trust is to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region (including Singapore) that are used primarily for healthcare and/or healthcare-related purposes (including but not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices), whether wholly or partially owned, and whether directly or indirectly held through the ownership of special purpose vehicles whose primary purpose is to own such real estate. Parkway Life Real Estate Investment Trust is domiciled in Singapore and was established on July 07, 2007.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Parkway Life Real Estate Investment Trust reported revenue of 156M SGD in FY2025 versus 121M SGD in FY2021, a compound +6.6%/yr. Reported net income was 153M SGD in FY2025, compounding −17.6%/yr from FY2021.
C2PU screens 51% overvalued. Compare with Welltower Inc →
Peer Group
REIT - Healthcare Facilities · 26 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Welltower Inc WELL | $230.27 | $41.85 | -82% |
| Ventas, Inc VTR | $89.01 | $17.91 | -80% |
| Omega Healthcare Investors, Inc OHI | $45.87 | $33.54 | -27% |
| Healthpeak Properties, Inc DOC | $20.66 | $6.95 | -66% |
| American Healthcare REIT, Inc AHR | $52.59 | $10.94 | -79% |
| CareTrust REIT, Inc CTRE | $39.16 | $22.79 | -42% |
| Healthcare Realty Trust Incorporated HR | $19.21 | $20.60 | +7% |
| Aedifica NV AED | €68.10 | €34.97 | -49% |
| Chartwell Retirement Residences CSHUN | C$21.17 | C$3.49 | -84% |
| Sabra Health Care REIT, Inc SBRA | $20.19 | $10.49 | -48% |
Compare Parkway Life Real Estate Investment Trust with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is Parkway Life Real Estate Investment Trust (C2PU) overvalued or undervalued?
What is the fair value of C2PU?
What is the quality score of C2PU?
What is the revenue of Parkway Life Real Estate Investment Trust (C2PU)?
What is the net profit margin of C2PU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Parkway Life Real Estate Investment Trust and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.